Limits...
A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study.

Patel MV, Patel KB, Gupta S, Michalsen A, Stapelfeldt E, Kessler CS - Evid Based Complement Alternat Med (2015)

Bottom Line: Based on Ayurvedic tradition, a standardized treatment protocol was developed and implemented, consisting of oral administration of single and compound herbal preparations combined with purificatory measures as well as dietary and lifestyle regimens.The outcomes were assessed by measuring liver functions through specific clinical features and laboratory parameters and by evaluating the Child-Pugh prognostic grade score.After 6 weeks of treatment and a follow-up period of 18 weeks, the outcomes showed statistically significant and clinically relevant improvements.

View Article: PubMed Central - PubMed

Affiliation: Department of Kayachikitsa, J. S. Ayurved College, College Road, Nadiad 387001, India.

ABSTRACT
Hepatic cirrhosis is one of the leading causes of death worldwide, especially if complicated by ascites. This chronic condition can be related to the classical disease entity jalodara in Traditional Indian Medicine (Ayurveda). The present paper aims to evaluate the general potential of Ayurvedic therapy for overall clinical outcomes in hepatic cirrhosis complicated by ascites (HCcA). In form of a nonrandomized, uncontrolled, single group, open-label observational clinical study, 56 patients fulfilling standardized diagnostic criteria for HCcA were observed during their treatment at the P. D. Patel Ayurveda Hospital, Nadiad, India. Based on Ayurvedic tradition, a standardized treatment protocol was developed and implemented, consisting of oral administration of single and compound herbal preparations combined with purificatory measures as well as dietary and lifestyle regimens. The outcomes were assessed by measuring liver functions through specific clinical features and laboratory parameters and by evaluating the Child-Pugh prognostic grade score. After 6 weeks of treatment and a follow-up period of 18 weeks, the outcomes showed statistically significant and clinically relevant improvements. Further larger and randomized trials on effectiveness, safety, and quality of the Ayurvedic approach in the treatment of HCcA are warranted to support these preliminary findings.

No MeSH data available.


Related in: MedlinePlus

Effect on prognosis according to Child-Pugh grade score: overall change (n = 56).
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4539059&req=5

fig1: Effect on prognosis according to Child-Pugh grade score: overall change (n = 56).

Mentions: At baseline (V0) 19 patients were graded in Group C (worst prognosis), 36 patients were graded in Group B (medium prognosis), and 1 was graded patient in Group A (best prognosis). After treatment (V1) 50 patients were found in Group A, 6 patients were found in Group B, and no patient was found in Group C (Figure 1).


A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study.

Patel MV, Patel KB, Gupta S, Michalsen A, Stapelfeldt E, Kessler CS - Evid Based Complement Alternat Med (2015)

Effect on prognosis according to Child-Pugh grade score: overall change (n = 56).
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4539059&req=5

fig1: Effect on prognosis according to Child-Pugh grade score: overall change (n = 56).
Mentions: At baseline (V0) 19 patients were graded in Group C (worst prognosis), 36 patients were graded in Group B (medium prognosis), and 1 was graded patient in Group A (best prognosis). After treatment (V1) 50 patients were found in Group A, 6 patients were found in Group B, and no patient was found in Group C (Figure 1).

Bottom Line: Based on Ayurvedic tradition, a standardized treatment protocol was developed and implemented, consisting of oral administration of single and compound herbal preparations combined with purificatory measures as well as dietary and lifestyle regimens.The outcomes were assessed by measuring liver functions through specific clinical features and laboratory parameters and by evaluating the Child-Pugh prognostic grade score.After 6 weeks of treatment and a follow-up period of 18 weeks, the outcomes showed statistically significant and clinically relevant improvements.

View Article: PubMed Central - PubMed

Affiliation: Department of Kayachikitsa, J. S. Ayurved College, College Road, Nadiad 387001, India.

ABSTRACT
Hepatic cirrhosis is one of the leading causes of death worldwide, especially if complicated by ascites. This chronic condition can be related to the classical disease entity jalodara in Traditional Indian Medicine (Ayurveda). The present paper aims to evaluate the general potential of Ayurvedic therapy for overall clinical outcomes in hepatic cirrhosis complicated by ascites (HCcA). In form of a nonrandomized, uncontrolled, single group, open-label observational clinical study, 56 patients fulfilling standardized diagnostic criteria for HCcA were observed during their treatment at the P. D. Patel Ayurveda Hospital, Nadiad, India. Based on Ayurvedic tradition, a standardized treatment protocol was developed and implemented, consisting of oral administration of single and compound herbal preparations combined with purificatory measures as well as dietary and lifestyle regimens. The outcomes were assessed by measuring liver functions through specific clinical features and laboratory parameters and by evaluating the Child-Pugh prognostic grade score. After 6 weeks of treatment and a follow-up period of 18 weeks, the outcomes showed statistically significant and clinically relevant improvements. Further larger and randomized trials on effectiveness, safety, and quality of the Ayurvedic approach in the treatment of HCcA are warranted to support these preliminary findings.

No MeSH data available.


Related in: MedlinePlus